Fortress Biotech, Inc. (FBIO)
1.87
0.00 (0.00%)
USD |
NASDAQ |
Oct 19, 15:33
Fortress Biotech Cash from Operations (Annual) : -71.34M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -71.34M |
| December 31, 2024 | -80.19M |
| December 31, 2023 | -128.22M |
| December 31, 2022 | -179.52M |
| December 31, 2021 | -116.54M |
| December 31, 2020 | -83.68M |
| December 31, 2019 | -94.96M |
| December 31, 2018 | -98.85M |
| December 31, 2017 | -81.30M |
| Date | Value |
|---|---|
| December 31, 2016 | -45.63M |
| December 31, 2015 | -20.38M |
| December 31, 2014 | -15.94M |
| December 31, 2013 | -29.65M |
| December 31, 2012 | -23.19M |
| December 31, 2011 | -10.95M |
| December 31, 2010 | -5.677M |
| December 31, 2009 | -2.351M |
| December 31, 2008 | -3.523M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | -88.63M |
| Kura Oncology, Inc. | -64.06M |
| Spero Therapeutics, Inc. | -12.62M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |